The stock is in a severe and sustained downtrend, with a 1-year price change of -16.46% and a more dramatic 6-month decline of -62.40%. Currently trading at $18.74, the price sits at just 13% of its 52-week range ($16.60 to $142.92), positioning it near its absolute lows, which suggests the market is pricing in significant fundamental deterioration or a deep value opportunity if the business can stabilize. Recent short-term momentum shows continued weakness, with the stock down 8.23% over the past month and 27.70% over the past three months, a deceleration that aligns with the longer-term downtrend and indicates persistent selling pressure. The stock's relative strength is deeply negative, underperforming the SPY by 45.50% over the past year, highlighting its significant idiosyncratic risk. Key technical levels are clearly defined, with immediate support at the 52-week low of $16.60 and major resistance far above at the 52-week high of $142.92. A breakdown below $16.60 would signal a complete loss of confidence and open the door to further declines, while any meaningful recovery would require a sustained move above the recent consolidation range in the low $20s. The stock's extreme volatility is evident in its max drawdown of -86.18%, demanding careful risk management for any potential position.

Revenue growth remains robust but shows signs of volatility; the most recent Q4 2025 revenue was $303.8 million, representing a strong 40.02% year-over-year increase. However, this follows a highly erratic quarterly pattern where Q3 2025 revenue was $274.2 million and Q2 2025 was $249.6 million, indicating lumpy growth rather than a smooth upward trajectory. The company is deeply unprofitable on a net income basis, reporting a Q4 2025 net loss of $226.6 million, which equates to a net margin of -74.58%. While the gross margin is healthy at 82.12% for the quarter, this is more than offset by massive operating expenses, leading to an operating margin of -64.36%, demonstrating that profitability remains a distant goal despite high gross profitability. The balance sheet shows a strong liquidity position with a current ratio of 2.58 and a low debt-to-equity ratio of 0.076, indicating minimal financial leverage risk. However, cash flow generation is inconsistent; while the company reported positive free cash flow of $39.2 million in Q4 2025 and has a trailing twelve-month FCF of $243.4 million, it also posted a significant operating cash outflow of -$178.2 million in Q2 2024. The negative Return on Equity of -82.78% and Return on Assets of -38.95% underscore profound inefficiency in generating profits from its capital base.